Lung Stent Market worth 0 Mn by 2024 – Exclusive Report by MarketsandMarkets™

Posted by Johnny on July 20th, 2022

Lung Stent Market is projected to reach USD 120 million by 2024 from USD 87 million in 2019, at a CAGR of 6.7%  according to a new report by MarketsandMarkets™.Factors such as increasing prevalence of lung cancer and chronic respiratory diseases and increasing preference for minimally invasive procedures are expected to drive the growth of the airway/lung stent market.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32315890

Browse in-depth TOC on " Lung Stent Market”

137 – Tables

34 – Figures 

164 – Pages

The tracheobronchial stents segment is expected to account for the largest share of the airway stent/lung stent market.

Based on type, the airway stent/lung stent market is categorized into tracheobronchial and laryngeal stents. the tracheobronchial segment is expected to account for the largest share of the airway/lung stent market.

By material, the metal stents segment is estimated to account for the largest share of the airway stent/lung stent market.

Based on the materials used to manufacture airway/lung stents, the market is segmented into metal, silicone, and hybrid stents. Certain advantages associated with metal stents, such as ease of insertion, thinner walls as compared to silicone lung stents, a lower risk of dislodgment or migration, and ability to adapt to the twisted airway are driving the growth of this segment.

The self-expandable stents segment is estimated to hold the largest share of the airway stent/lung stent market.

Based on the product, the airway stent/lung stent market is segmented into expandable and non-expandable stents. Of this, the expandable stents segment is estimated to hold a larger share of the market.

Hospitals will account for the largest share of the airway stent/lung stent market.

Based on end user, the airway stent/lung stent market is segmented into hospitals and ambulatory surgical centers. the hospitals segment will dominate the airway/lung stents market.

Request Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=32315890

North America is expected to dominate the market

North America is estimated to account for the largest share of the airway/lung stent market, followed by Europe. North America's dominance is largely due to the presence of several large hospitals, strong health care infrastructure, increasing disease prevalence, a growing geriatric population and rising health care spending.

The key players operating in the airway stent/lung stent market include Boston Scientific Corporation (US), Taewoong Medical Co., Ltd. (South Korea), Micro-Tech (Nanjing) Co., Ltd. (China), Novatech SA (France), Boston Medical Products, Inc. (US), E. Benson Hood Laboratories, Inc. (US), Merit Medical Systems, Inc. (US), Cook Group (US), EFER ENDOSCOPY (France), ENDO-FLEX GmbH (Germany), Standard Sci. Tech Inc. (South Korea), and Stening SRL (Argentina), among others.

Get 10% Free Customization on this Report @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=32315890

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.